Stellate Ganglion Block for Prevention of Post Mastectomy Depression
RecruitingNot applicableNCT06263907
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Complications after mastectomy include chronic pain and depression.
Study details
- Official title
- Preemptive Efficacy of Stellate Ganglion Block for Prevention of Post Mastectomy Depression
- Conditions
- Interventions
- Procedure: Stellate gangalion block
- Sponsor
- Mansoura University
- Start date
- 2024-03-01
- Primary completion
- 2027-11-30
- Sex
- Female
- Age range
- from 21 Years to 65 Years
- Results posted
- No results posted in this snapshot
- Countries
- Egypt
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Female patients * Age ranging from 18 to 65 years * American Society of Anesthesiologists (ASA) no more than II * Had unilateral cancer breast * Scheduled to do unilateral modified radical mastectomy Exclusion Criteria: * Pregnant female * Existing Horner syndrome * Had any neuromuscular disease * Had allergy to local anesthetics * History of use of analgesics * Had any deformity or a previous surgery in the neck or ipsilateral arm or breast * Had any contraindication to the procedure (coagulation disorders, local infection, sepsis) * Had any contraindication to the sympathetic blockade (decompensate cardiopulmonary or hemodynamic disorders) * History of psychotic disorder including depression, bipolar disorder or personality disorder * Patient with Beck Depression Inventory (BDI) score more than 13
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06263907